Microbiomes in respiratory health and disease: An Asia-Pacific perspective

Respirology

Volumn 22, Issue 2, 2017, Pages 240-250

  Chotirmall, Sanjay H ^a   Gellatly, Shaan L ^b   Budden, Kurtis F ^b   Mac Aogain, Micheál ^a   Shukla, Shakti D ^b   Wood, David L A ^c   Hugenholtz, Philip ^c   Pethe, Kevin ^a   Hansbro, Philip M ^b  

^a NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^b HUNTER MEDICAL RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

asthma; chronic obstructive pulmonary disease; cystic fibrosis; gut; health; microbiome; mouse model; prevention; respiratory disease; treatment

Indexed keywords

ANTIBIOTIC AGENT; CIGARETTE SMOKE; SHORT CHAIN FATTY ACID;

AGING; AIR POLLUTION; ANTIBIOTIC RESISTANCE; ASTHMA; BACTEROIDETES; BIFIDOBACTERIUM; BRONCHIECTASIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMMENSAL; CYSTIC FIBROSIS; DIET; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG MEGADOSE; DYSBIOSIS; FIRMICUTES; HUMAN; IMMUNOSENESCENCE; INTESTINE FLORA; LUNG INFECTION; MICROBIAL DIVERSITY; MICROBIOME; NONHUMAN; PREVALENCE; PROGNOSIS; PROTEOBACTERIA; RESPIRATORY TRACT DISEASE; REVIEW; SMOKING; AUSTRALIA; FAR EAST; IMMUNOLOGY; MICROBIOLOGY; MICROFLORA; NEW ZEALAND; RESPIRATORY SYSTEM; SMOKE; SOUTHEAST ASIA;

AGING; AIR POLLUTION; ASIA, SOUTHEASTERN; AUSTRALIA; DIET; FAR EAST; GASTROINTESTINAL MICROBIOME; HUMANS; MICROBIOTA; NEW ZEALAND; RESPIRATORY SYSTEM; RESPIRATORY TRACT DISEASES; SMOKE;

EID: 85009830159     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12971     Document Type: Review

References (135)

1. Marchesi JR, Ravel J. The vocabulary of microbiome research: a proposal. Microbiome 2015; 3: 31.
2. Zeng H, Lazarova DL, Bordonaro M. Mechanisms linking dietary fiber, gut microbiota and colon cancer. World J. Gastrointest. Oncol. 2014; 6: 41–51.
3. Fagundes CT, Souza DG, Nicoli JR, Teixeira MM. Control of host inflammatory responsiveness by indigenous microbiota reveals an adaptive component of the innate immune system. Microbes Infect. 2011; 13: 1121–32.
4. Huttenhower C, Gevers D, Knight R, Abubucker S, Badger JH, Chinwalla AT, Creasy HH, Earl AM, FitzGerald MG, Fulton RS et al. Structure, function and diversity of the healthy human microbiome. Nature 2012; 486: 207–14.
5. Noverr MC, Huffnagle BG. Does the microbiota regulate imune responses outside the gut? Trends Microbiol. 2004; 12: 562–8.
6. Morgan X, Segata N, Huttenhower C. Biodiversity and functional genomics in the human microbiome. Trends Genet. 2013; 29: 51–8.
7. Dogra S, Sakwinska O, Soh S, Ngom-Bru C, Bruck W, Berger B, Brussow H, Karnani N, Lee Y, Yap F et al. Rate of establishing the gut microbiota in infancy has consequences for future health. Gut Microbes 2015; 6: 321–5.
8. Sze MA, Dimitriu PA, Hayashi S, Elliott WM, McDonough JE, Gosselink JV, Cooper J, Sin DD, Mohn WW, Hogg JC. The lung tissue microbiome in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2012; 185: 1073–80.
9. Venkataraman A, Bassis CM, Beck JM, Young VB, Curtis JL, Huffnagle GB, Schmidt TM. Application of a neutral community model to assess structuring of the human lung microbiome. MBio 2015; 6: e02284–14.
10. Bassis C, Erb-Downward J, Dickson R, Freeman C, Schmidt T, Young V, Beck J, Curtis J, Huffnagle G. Analysis of the upper respiratory tract microbiotas as the source of the lung and gastric microbiotas in healthy individuals. MBio 2015; 6: e00037–15.
11. Morris A, Beck J, Schloss P, Campbell T, Crothers K, Curtis J, Flores S, Fontenot A, Ghedin E, Huang L et al. Comparison of the respiratory microbiome in healthy nonsmokers and smokers. Am. J. Respir. Crit. Care Med. 2013; 187: 1067–75.
12. Dickson R, Huffnagle G. The lung microbiome: new principles for respiratory bacteriology in health and disease. PLoS Pathog. 2015; 11: e1004923.
13. Dickson RP, Erb-Downward JR, Huffnagle GB. Homeostasis and its disruption in the lung microbiome. Am. J. Physiol. Lung Cell. Mol. Physiol. 2015; 309: L1047–55.
14. Hilty M, Burke C, Pedro H, Cardenas P, Bush A, Bossley C, Davies J, Ervine A, Poulter L, Pachter L et al. Disordered microbial communities in asthmatic airways. PLoS One 2010; 5: e8578.
15. Goleva E, Jackson L, Harris J, Robertson C, Sutherland E, Hall C, Good J, Gelfand E, Martin R, Leung D. The effects of airway microbiome on corticosteroid responsiveness in asthma. Am. J. Respir. Crit. Care Med. 2013; 188: 1193–201.
16. Saeedi P, Salimian J, Ahmadi A, Imani FA. The transient but not resident (TBNR) microbiome: a Yin Yang model for lung immune system. Inhal. Toxicol. 2015; 27: 451–61.
17. Budden KF, Gellatly SL, Wood DLA, Cooper MA, Morrison M, Hugenholtz P, Hansbro PM. Emerging pathogenic links between microbiota and the gut-lung axis. Nat. Rev. Microbiol. 2016; 15: 55–63.
18. Wymore Brand M, Wannemuehler MJ, Phillips GJ, Proctor A, Overstreet AM, Jergens AE, Orcutt RP, Fox JG. The altered Schaedler flora: continued applications of a defined murine microbial community. ILAR J. 2015; 56: 169–78.
19. Russell SL, Gold MJ, Hartmann M, Willing BP, Thorson L, Wlodarska M, Gill N, Blanchet MR, Mohn WW, McNagny KM et al. Early life antibiotic-driven changes in microbiota enhance susceptibility to allergic asthma. EMBO Rep. 2012; 13: 440–7.
20. Thorburn A, McKenzie C, Shen S, Stanley D, Macia L, Mason L, Roberts L, Wong C, Shim R, Robert R et al. Evidence that asthma is a developmental origin disease influenced by maternal diet and bacterial metabolites. Nat. Commun. 2015; 6: 7320.
21. Chambers DC, Gellatly SL, Hugenholtz P, Hansbro PM. JTD special edition ‘Hot Topics in COPD’–the microbiome in COPD. J. Thorac. Dis. 2014; 6: 1525–31.
22. Mateer SW, Maltby S, Marks E, Foster PS, Horvat JC, Hansbro PM, Keely S. Potential mechanisms regulating pulmonary pathology in inflammatory bowel disease. J. Leukoc. Biol. 2015; 98: 727–37.
23. Keely S, Talley NJ, Hansbro PM. Pulmonary-intestinal cross-talk in mucosal inflammatory disease. Mucosal Immunol. 2012; 5: 7–18.
24. Biedermann L, Brulisauer K, Zeitz J, Frei P, Scharl M, Vavricka SR, Fried M, Loessner MJ, Rogler G, Schuppler M. Smoking cessation alters intestinal microbiota: insights from quantitative investigations on human fecal samples using FISH. Inflamm. Bowel Dis. 2014; 20: 1496–501.
25. Pragman A, Kim H, Reilly C, Wendt C, Isaacson R. The lung microbiome in moderate and severe chronic obstructive pulmonary disease. PLoS One 2012; 7: e47305.
26. Hevia A, Milani C, López P, Donado CD, Cuervo A, González S, Suárez A, Turroni F, Gueimonde M, Ventura M et al. Allergic patients with long-term asthma display low levels of Bifidobacterium adolescentis. PLoS One 2016; 11: e0147809.
27. Bruzzese E, Callegari M, Raia V, Viscovo S, Scotto R, Ferrari S, Morelli L, Buccigrossi V, Lo Vecchio A, Ruberto E et al. Disrupted intestinal microbiota and intestinal inflammation in children with cystic fibrosis and its restoration with Lactobacillus GG: a randomised clinical trial. PLoS One 2014; 9: e87796.
28. Foster PS, Plank M, Collison A, Tay HL, Kaiko GE, Li J, Johnston SL, Hansbro PM, Kumar RK, Yang M et al. The emerging role of microRNAs in regulating immune and inflammatory responses in the lung. Immunol. Rev. 2013; 253: 198–215.
29. Kim RY, Horvat JC, Pinkerton JW, Starkey MR, Essilfie AT, Jones B, Haw TJ, Keely S, Mattes J, Adcock IM et al. MicroRNA-21 drives severe, steroid-insensitive experimental asthma through phosphoinositide-3-kinase. J. Allergy Clin. Immunol. 2016. doi: 10.1016/j.jaci.2016.04.038.
30. Kim RY, Pinkerton JW, Gibson PG, Cooper MA, Horvat JC, Hansbro PM. Inflammasomes in COPD and neutrophilic asthma. Thorax 2015; 70: 1199–201.
31. Tay HL, Kaiko GE, Plank M, Li J, Maltby S, Essilfie AT, Jarnicki A, Yang M, Mattes J, Hansbro PM et al. Antagonism of miR-328 increases the antimicrobial function of macrophages and neutrophils and rapid clearance of non-typeable Haemophilus influenzae (NTHi) from infected lung. PLoS Pathog. 2015; 11: e1004549.
32. Clarke T. Early innate immunity to bacterial infection in the lung is regulated systemically by the commensal microbiota via Nod-like receptor ligands. Infect. Immun. 2014; 82: 4596–606.
33. Fagundes CT, Amaral FA, Vieira AT, Soares AC, Pinho V, Nicoli JR, Vieira LQ, Teixeira MM, Souza DG. Transient TLR activation restores inflammatory response and ability to control pulmonary bacterial infection in germfree mice. J. Immunol. 2012; 188: 1411–20.
34. Trompette A, Gollwitzer E, Yadava K, Sichelstiel A, Sprenger N, Ngom-Bru C, Blanchard C, Junt J, Nicod L, Harris N et al. Gut microbiota metabolism of dietary fibre influences allergic airway disease and hematopoiesis. Nat. Med. 2014; 20: 159–66.
35. Arrieta MC, Stiemsma LT, Dimitriu PA, Thorson L, Russell S, Yurist-Doutsch S, Kuzeljevic B, Gold MJ, Britton HM, Lefebvre DL et al. Early infancy microbial and metabolic alterations affect risk of childhood asthma. Sci. Transl. Med. 2015; 7: 307ra152.
36. Wang J, Li F, Wei H, Lian Z, Sun R, Tian Z. Respiratory influenza virus infection induces intestinal immune injury via microbiota-mediated Th17 cell-dependent inflammation. J. Exp. Med. 2014; 211: 2397–410.
37. Larsen J, Musavian H, Butt T, Ingvorsen C, Thysen A, Brix S. Chronic obstructive pulmonary disease and asthma-associated Proteobacteria, but not commensal Prevotella spp., promote Toll-like receptor 2-independent lung inflammation and pathology. Immunology 2015; 144: 333–42.
38. Simpson JL, Baines KJ, Horvat JC, Essilfie AT, Brown AC, Tooze M, McDonald VM, Gibson PG, Hansbro PM. COPD is characterized by increased detection of Haemophilus influenza, Streptococcus pneumoniae and a deficiency of Baccillus species. Respirology 2016; 21: 697–704.
39. Wood LG, Simpson JL, Hansbro PM, Gibson PG. Potentially pathogenic bacteria cultured from the sputum of stable asthmatics are associated with increased 8-isoprostane and airway neutrophilia. Free Radic. Res. 2010; 44: 146–54.
40. King S, Glanville J, Sanders ME, Fitzgerald A, Varley D. Effectiveness of probiotics on the duration of illness in healthy children and adults who develop common acute respiratory infectious conditions: a systematic review and meta-analysis. Br. J. Nutr. 2014; 112: 41–54.
41. Luoto R, Ruuskanen O, Waris M, Kalliomäki M, Salminen S, Isolauri E. Prebiotic and probiotic supplementation prevents rhinovirus infections in preterm infants: a randomized placebo-controlled trial. J. Allergy Clin. Immunol. 2014; 133: 405–13.
42. Hugo Pan-Asian SNP Consortium, Abdulla MA, Ahmed I, Assawamakin A, Bhak J, Brahmachari SK, Calacal GC, Chaurasia A, Chen CH, Chen J et al.; Indian Genome Variation Consortium. Mapping human genetic diversity in Asia. Science 2009; 326: 1541–5.
43. Jamrozik E, Musk AW. Respiratory health issues in the Asia-Pacific region: an overview. Respirology 2011; 16: 3–12. doi: 10.1111/j.1440-1843.2010.01844.x.
44. Costalonga M, Herzberg MC. The oral microbiome and the immunobiology of periodontal disease and caries. Immunol. Lett. 2014; 162: 22–38. doi: 10.1016/j.imlet.2014.08.017.
45. Cabrera-Rubio R, Garcia-Nunez M, Seto L, Anto JM, Moya A, Monso E, Mira A. Microbiome diversity in the bronchial tracts of patients with chronic obstructive pulmonary disease. J. Clin. Microbiol. 2012; 50: 3562–8. doi: 10.1128/JCM.00767-12.
46. Huang S, Li R, Zeng X, He T, Zhao H, Chang A, Bo C, Chen J, Yang F, Knight R et al. Predictive modeling of gingivitis severity and susceptibility via oral microbiota. ISME J. 2014; 8: 1768–80.
47. Lim MY, Yoon HS, Rho M, Sung J, Song YM, Lee K, Ko G. Analysis of the association between host genetics, smoking, and sputum microbiota in healthy humans. Sci. Rep. 2016; 6: 23745.
48. Chong CW, Ahmad AF, Lim YA, Teh CS, Yap IK, Lee SC, Chin YT, Loke P, Chua KH. Effect of ethnicity and socioeconomic variation to the gut microbiota composition among pre-adolescent in Malaysia. Sci. Rep. 2015; 5: 13338.
49. Chotirmall SH, Burke CM. Aging and the microbiome: implications for asthma in the elderly? Expert Rev. Respir. Med. 2015; 9: 125–8.
50. Wu J, Liu W, He L, Huang F, Chen J, Cui P, Shen Y, Zhao J, Wang W, Zhang Y et al. Sputum microbiota associated with new, recurrent and treatment failure tuberculosis. PLoS One 2013; 8: e83445.
51. Nakayama J, Watanabe K, Jiang J, Matsuda K, Chao SH, Haryono P, La-Ongkham O, Sarwoko MA, Sujaya IN, Zhao L et al. Diversity in gut bacterial community of school-age children in Asia. Sci. Rep. 2015; 5: 8397.
52. Zhang J, Guo Z, Lim AA, Zheng Y, Koh EY, Ho D, Qiao J, Huo D, Hou Q, Huang W et al. Mongolians core gut microbiota and its correlation with seasonal dietary changes. Sci. Rep. 2014; 4: 5001.
53. Ghosh TS, Gupta SS, Bhattacharya T, Yadav D, Barik A, Chowdhury A, Das B, Mande SS, Nair GB. Gut microbiomes of Indian children of varying nutritional status. PLoS One 2014; 9: e95547.
54. Vogtmann E, Flores R, Yu G, Freedman ND, Shi J, Gail MH, Dye BA, Wang GQ, Klepac-Ceraj V, Paster BJ et al. Association between tobacco use and the upper gastrointestinal microbiome among Chinese men. Cancer Causes Control 2015; 26: 581–8.
55. Tyakht AV, Kostryukova ES, Popenko AS, Belenikin MS, Pavlenko AV, Larin AK, Karpova IY, Selezneva OV, Semashko TA, Ospanova EA et al. Human gut microbiota community structures in urban and rural populations in Russia. Nat. Commun. 2013; 4: 2469.
56. Hisada T, Endoh K, Kuriki K. Inter- and intra-individual variations in seasonal and daily stabilities of the human gut microbiota in Japanese. Arch. Microbiol. 2015; 197: 919–34.
57. Han K, Bose S, Wang JH, Kim BS, Kim MJ, Kim EJ, Kim H. Contrasting effects of fresh and fermented kimchi consumption on gut microbiota composition and gene expression related to metabolic syndrome in obese Korean women. Mol. Nutr. Food Res. 2015; 59: 1004–8.
58. O'Mahony C, Scully P, O'Mahony D, Murphy S, O'Brien F, Lyons A, Sherlock G, MacSharry J, Kiely B, Shanahan F et al. Commensal-induced regulatory T cells mediate protection against pathogen-stimulated NF-kappaB activation. PLoS Pathog. 2008; 4: e1000112.
59. Yatsunenko T, Rey FE, Manary MJ, Trehan I, Dominguez-Bello MG, Contreras M, Magris M, Hidalgo G, Baldassano RN, Anokhin AP et al. Human gut microbiome viewed across age and geography. Nature 2012; 486: 222–7.
60. Suzuki TA, Worobey M. Geographical variation of human gut microbial composition. Biol. Lett. 2014; 10: 20131037.
61. Goodrich JK, Waters JL, Poole AC, Sutter JL, Koren O, Blekhman R, Beaumont M, Van Treuren W, Knight R, Bell JT et al. Human genetics shape the gut microbiome. Cell 2014; 159: 789–99.
62. Takeshita T, Matsuo K, Furuta M, Shibata Y, Fukami K, Shimazaki Y, Akifusa S, Han DH, Kim HD, Yokoyama T et al. Distinct composition of the oral indigenous microbiota in South Korean and Japanese adults. Sci. Rep. 2014; 4: 6990.
63. Zhang X, Zhang D, Jia H, Feng Q, Wang D, Liang D, Wu X, Li J, Tang L, Li Y et al. The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment. Nat. Med. 2015; 21: 895–905.
64. Rogers GB, van der Gast CJ, Serisier DJ. Predominant pathogen competition and core microbiota divergence in chronic airway infection. ISME J. 2015; 9: 217–25.
65. Hosgood HD 3rd, Sapkota AR, Rothman N, Rohan T, Hu W, Xu J, Vermeulen R, He X, White JR, Wu G et al. The potential role of lung microbiota in lung cancer attributed to household coal burning exposures. Environ. Mol. Mutagen. 2014; 55: 643–51.
66. Cheung MK, Lam WY, Fung WY, Law PT, Au CH, Nong W, Kam KM, Kwan HS, Tsui SK. Sputum microbiota in tuberculosis as revealed by 16S rRNA pyrosequencing. PLoS One 2013; 8: e54574.
67. Rogers GB, van der Gast CJ, Cuthbertson L, Thomson SK, Bruce KD, Martin ML, Serisier DJ. Clinical measures of disease in adult non-CF bronchiectasis correlate with airway microbiota composition. Thorax 2013; 68: 731–7.
68. Rogers GB, Zain NM, Bruce KD, Burr LD, Chen AC, Rivett DW, McGuckin MA, Serisier DJ. A novel microbiota stratification system predicts future exacerbations in bronchiectasis. Ann. Am. Thorac. Soc. 2014; 11: 496–503.
69. Keicho N, Hijikata M. Genetic predisposition to diffuse panbronchiolitis. Respirology 2011; 16: 581–8. doi: 10.1111/j.1440-1843.2011.01946.x.
70. Lin X, Lu J, Yang M, Dong BR, Wu HM. Macrolides for diffuse panbronchiolitis. Cochrane Database Syst. Rev. 2015; 1: CD007716. doi: 10.1002/14651858.CD007716.pub4.
71. Candela M, Maccaferri S, Turroni S, Carnevali P, Brigidi P. Functional intestinal microbiome, new frontiers in prebiotic design. Int. J. Food Microbiol. 2010; 140: 93–101.
72. Rios-Covian D, Gueimonde M, Duncan SH, Flint HJ, de los Reyes-Gavilan CG. Enhanced butyrate formation by cross-feeding between Faecalibacterium prausnitzii and Bifidobacterium adolescentis. FEMS Microbiol. Lett. 2015; 362. doi: 10.1093/femsle/fnv176.
73. Hrncir T, Stepankova R, Kozakova H, Hudcovic T, Tlaskalova-Hogenova H. Gut microbiota and lipopolysaccharide content of the diet influence development of regulatory T cells: studies in germ-free mice. BMC Immunol. 2008; 9: 65.
74. Rhee KJ, Sethupathi P, Driks A, Lanning DK, Knight KL. Role of commensal bacteria in development of gut-associated lymphoid tissues and preimmune antibody repertoire. J. Immunol. 2004; 172: 1118–24.
75. Thorburn AN, Hansbro PM. Harnessing regulatory T cells to suppress asthma: from potential to therapy. Am. J. Respir. Cell Mol. Biol. 2010; 43: 511–9.
76. Shimada Y, Kinoshita M, Harada K, Mizutani M, Masahata K, Kayama H, Takeda K. Commensal bacteria-dependent indole production enhances epithelial barrier function in the colon. PLoS One 2013; 8: e80604.
77. Fukuda S, Toh H, Hase K, Oshima K, Nakanishi Y, Yoshimura K, Tobe T, Clarke JM, Topping DL, Suzuki T et al. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 2011; 469: 543–7.
78. Maslowski KM, Vieira AT, Ng A, Kranich J, Sierro F, Yu D, Schilter HC, Rolph MS, Mackay F, Artis D et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 2009; 461: 1282–6.
79. Kummeling I, Stelma FF, Dagnelie PC, Snijders BE, Penders J, Huber M, van Ree R, van den Brandt PA, Thijs C. Early life exposure to antibiotics and the subsequent development of eczema, wheeze, and allergic sensitization in the first 2 years of life: the KOALA Birth Cohort Study. Pediatrics 2007; 119: e225–31.
80. Penders J, Thijs C, van den Brandt PA, Kummeling I, Snijders B, Stelma F, Adams H, van Ree R, Stobberingh EE. Gut microbiota composition and development of atopic manifestations in infancy: the KOALA Birth Cohort Study. Gut 2007; 56: 661–7.
81. Preston JA, Thorburn AN, Starkey MR, Beckett EL, Horvat JC, Wade MA, O'Sullivan BJ, Thomas R, Beagley KW, Gibson PG et al. Streptococcus pneumoniae infection suppresses allergic airways disease by inducing regulatory T-cells. Eur. Respir. J. 2011; 37: 53–64.
82. Eiseman B, Silen W, Bascom GS, Kauvar AJ. Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery 1958; 44: 854–9.
83. Zhang F, Luo W, Shi Y, Fan Z, Ji G. Should we standardize the 1,700-year-old fecal microbiota transplantation? Am. J. Gastroenterol. 2012; 107: 1755; author reply p.1755–6.
84. Britton RA, Young VB. Role of the intestinal microbiota in resistance to colonization by Clostridium difficile. Gastroenterology 2014; 146: 1547–53.
85. Lawley TD, Clare S, Walker AW, Stares MD, Connor TR, Raisen C, Goulding D, Rad R, Schreiber F, Brandt C et al. Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice. PLoS Pathog. 2012; 8: e1002995.
86. Petrof EO, Gloor GB, Vanner SJ, Weese SJ, Carter D, Daigneault MC, Brown EM, Schroeter K, Allen-Vercoe E. Stool substitute transplant therapy for the eradication of Clostridium difficile infection: ‘RePOOPulating’ the gut. Microbiome 2013; 1: 3.
87. Ortqvist AK, Lundholm C, Kieler H, Ludvigsson JF, Fall T, Ye W, Almqvist C. Antibiotics in fetal and early life and subsequent childhood asthma: nationwide population based study with sibling analysis. BMJ 2014; 349: g6979.
88. Essilfie AT, Horvat JC, Kim RY, Mayall JR, Pinkerton JW, Beckett EL, Starkey MR, Simpson JL, Foster PS, Gibson PG et al. Macrolide therapy suppresses key features of experimental steroid-sensitive and steroid-insensitive asthma. Thorax 2015; 70: 458–67.
89. Rutten EP, Lenaerts K, Buurman WA, Wouters EF. Disturbed intestinal integrity in patients with COPD: effects of activities of daily living. Chest 2014; 145: 245–52.
90. Biedermann L, Zeitz J, Mwinyi J, Sutter-Minder E, Rehman A, Ott SJ, Steurer-Stey C, Frei A, Frei P, Scharl M et al. Smoking cessation induces profound changes in the composition of the intestinal microbiota in humans. PLoS One 2013; 8: e59260.
91. Gold MJ, Hiebert PR, Park HY, Stefanowicz D, Le A, Starkey MR, Deane A, Brown AC, Liu G, Horvat JC et al. Mucosal production of uric acid by airway epithelial cells contributes to particulate matter-induced allergic sensitization. Mucosal Immunol. 2016; 9: 809–20.
92. Kish L, Hotte N, Kaplan GG, Vincent R, Tso R, Ganzle M, Rioux KP, Thiesen A, Barkema HW, Wine E et al. Environmental particulate mater induces murine intestinal inflammatory responses and alters the gut microbiome. PLoS One 2013; 8: e62220.
93. Hirota JA, Gold MJ, Hiebert PR, Parkinson LG, Wee T, Smith D, Hansbro PM, Carlsten C, VanEeden S, Sin DD et al. The nucleotide-binding domain, leucine-rich repeat protein 3 inflammasome/IL-1 receptor I axis mediates innate, but not adaptive, immune responses after exposure to particulate matter under 10 εM. Am. J. Respir. Cell Mol. Biol. 2015; 52: 96–105.
94. D'Costa VM, King CE, Kalan L, Morar M, Sung WW, Schwarz C, Froese D, Zazula G, Calmels F, Debruyne R et al. Antibiotic resistance is ancient. Nature 2011; 477: 457–61.
95. Davies J. Inactivation of antibiotics and the dissemination of resistance genes. Science 1994; 264: 375–82.
96. Zhang L, Huang Y, Zhou Y, Buckley T, Wang HH. Antibiotic administration routes significantly influence the levels of antibiotic resistance in gut microbiota. Antimicrob. Agents Chemother. 2013; 57: 3659–66.
97. Jernberg C, Lofmark S, Edlund C, Jansson JK. Long-term ecological impacts of antibiotic administration on the human intestinal microbiota. ISME J. 2007; 1: 56–66.
98. Vasseur MV, Laurentie M, Rolland JG, Perrin-Guyomard A, Henri J, Ferran AA, Toutain PL, Bousquet-Melou A. Low or high doses of cefquinome targeting low or high bacterial inocula cure Klebsiella pneumoniae lung infections but differentially impact the levels of antibiotic resistance in fecal flora. Antimicrob. Agents Chemother. 2014; 58: 1744–8.
99. Modi SR, Lee HH, Spina CS, Collins JJ. Antibiotic treatment expands the resistance reservoir and ecological network of the phage metagenome. Nature 2013; 499: 219–22.
100. Rumbo C, Fernandez-Moreira E, Merino M, Poza M, Mendez JA, Soares NC, Mosquera A, Chaves F, Bou G. Horizontal transfer of the OXA-24 carbapenemase gene via outer membrane vesicles: a new mechanism of dissemination of carbapenem resistance genes in Acinetobacter baumannii. Antimicrob. Agents Chemother. 2011; 55: 3084–90.
101. Zhang X, McDaniel AD, Wolf LE, Keusch GT, Waldor MK, Acheson DW. Quinolone antibiotics induce Shiga toxin-encoding bacteriophages, toxin production, and death in mice. J. Infect. Dis. 2000; 181: 664–70.
102. Willner D, Furlan M, Haynes M, Schmieder R, Angly FE, Silva J, Tammadoni S, Nosrat B, Conrad D, Rohwer F. Metagenomic analysis of respiratory tract DNA viral communities in cystic fibrosis and non-cystic fibrosis individuals. PLoS One 2009; 4: e7370.
103. Fancello L, Desnues C, Raoult D, Rolain JM. Bacteriophages and diffusion of genes encoding antimicrobial resistance in cystic fibrosis sputum microbiota. J. Antimicrob. Chemother. 2011; 66: 2448–54.
104. Fodor AA, Klem ER, Gilpin DF, Elborn JS, Boucher RC, Tunney MM, Wolfgang MC. The adult cystic fibrosis airway microbiota is stable over time and infection type, and highly resilient to antibiotic treatment of exacerbations. PLoS One 2012; 7: e45001.
105. Cuthbertson L, Rogers GB, Walker AW, Oliver A, Green LE, Daniels TW, Carroll MP, Parkhill J, Bruce KD, van der Gast CJ. Respiratory microbiota resistance and resilience to pulmonary exacerbation and subsequent antimicrobial intervention. ISME J. 2015; 10: 1081–91.
106. Chotirmall SH, Smith SG, Gunaratnam C, Cosgrove S, Dimitrov BD, O'Neill SJ, Harvey BJ, Greene CM, McElvaney NG. Effect of estrogen on Pseudomonas mucoid and exacerbations in cystic fibrosis. N. Engl. J. Med. 2012; 366: 1978–86.
107. Chmiel JF, Aksamit TR, Chotirmall SH, Dasenbrook EC, Elborn JS, LiPuma JJ, Ranganathan SC, Waters VJ, Ratjen FA. Antibiotic management of lung infections in cystic fibrosis. I. The microbiome, methicillin-resistant Staphylococcus aureus, gram-negative bacteria, and multiple infections. Ann. Am. Thorac. Soc. 2014; 11: 1120–9.
108. Chmiel JF, Aksamit TR, Chotirmall SH, Dasenbrook EC, Elborn JS, LiPuma JJ, Ranganathan SC, Waters VJ, Ratjen FA. Antibiotic management of lung infections in cystic fibrosis. II. Nontuberculous mycobacteria, anaerobic bacteria, and fungi. Ann. Am. Thorac. Soc. 2014; 11: 1298–306.
109. Biagi E, Nylund L, Candela M, Ostan R, Bucci L, Pini E, Nikkila J, Monti D, Satokari R, Franceschi C et al. Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PLoS One 2010; 5: e10667.
110. Claesson MJ, Jeffery IB, Conde S, Power SE, O'Connor EM, Cusack S, Harris HM, Coakley M, Lakshminarayanan B, O'Sullivan O et al. Gut microbiota composition correlates with diet and health in the elderly. Nature 2012; 488: 178–84.
111. Harvill ET. Cultivating our “frienemies”: viewing immunity as microbiome management. MBio 2013; 4.
112. Russell SL, Gold MJ, Willing BP, Thorson L, McNagny KM, Finlay BB. Perinatal antibiotic treatment affects murine microbiota, immune responses and allergic asthma. Gut Microbes 2013; 4: 158–64.
113. Vital M, Harkema JR, Rizzo M, Tiedje J, Brandenberger C. Alterations of the murine gut microbiome with age and allergic airway disease. J. Immunol. Res. 2015; 2015: 892568.
114. Abrahamsson TR, Jakobsson HE, Andersson AF, Bjorksten B, Engstrand L, Jenmalm MC. Low gut microbiota diversity in early infancy precedes asthma at school age. Clin. Exp. Allergy 2014; 44: 842–50.
115. Marsland BJ, Trompette A, Gollwitzer ES. The gut-lung axis in respiratory disease. Ann. Am. Thorac. Soc. 2015; 12: S150–6.
116. Murray MA, Chotirmall SH. The impact of immunosenescence on pulmonary disease. Mediators Inflamm. 2015; 2015: 692546.
117. Simpson JL, McDonald VM, Baines KJ, Oreo KM, Wang F, Hansbro PM, Gibson PG. Influence of age, past smoking, and disease severity on TLR2, neutrophilic inflammation, and MMP-9 levels in COPD. Mediators Inflamm. 2013; 2013: 462934.
118. Cox MJ, Allgaier M, Taylor B, Baek MS, Huang YJ, Daly RA, Karaoz U, Andersen GL, Brown R, Fujimura KE et al. Airway microbiota and pathogen abundance in age-stratified cystic fibrosis patients. PLoS One 2010; 5: e11044.
119. Hsu AC, Starkey MR, Hanish I, Parsons K, Haw TJ, Howland LJ, Barr I, Mahony JB, Foster PS, Knight DA et al. Targeting PI3K-p110alpha suppresses influenza virus infection in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2015; 191: 1012–23.
120. Beckett EL, Stevens RL, Jarnicki AG, Kim RY, Hanish I, Hansbro NG, Deane A, Keely S, Horvat JC, Yang M et al. A new short-term mouse model of chronic obstructive pulmonary disease identifies a role for mast cell tryptase in pathogenesis. J. Allergy Clin. Immunol. 2013; 131: 752–62.
121. Hansbro PM, Hamilton MJ, Fricker M, Gellatly SL, Jarnicki AG, Zheng D, Frei SM, Wong GW, Hamadi S, Zhou S et al. Importance of mast cell Prss31/transmembrane tryptase/tryptase-gamma in lung function and experimental chronic obstructive pulmonary disease and colitis. J. Biol. Chem. 2014; 289: 18214–27.
122. Haw TJ, Starkey MR, Nair PM, Pavlidis S, Liu G, Nguyen DH, Hsu AC, Hanish I, Kim RY, Collison AM et al. Tumour necrosis factor-related apoptosis-inducing ligand promotes cigarette smoke-induced experimental COPD. Mucosal Immunol. 2016; 9: 859–72.
123. Liu G, Cooley MA, Jarnicki AG, Hsu ACY, Nair PM, Haw TJ, Fricker M, Gellatly SL, Kim RY, Inman MD et al. Fibulin-1 regulates the pathogenesis of tissue remodeling in respiratory diseases. JCI Insight 2016; 1: e86380.
124. Fricker M, Deane A, Hansbro PM. Animal models of chronic obstructive pulmonary disease. Expert Opin. Drug Discov. 2014; 9: 629–45.
125. Essilfie AT, Simpson JL, Dunkley ML, Morgan LC, Oliver BG, Gibson PG, Foster PS, Hansbro PM. Combined Haemophilus influenzae respiratory infection and allergic airways disease drives chronic infection and features of neutrophilic asthma. Thorax 2012; 67: 588–99.
126. Starkey MR, Jarnicki AG, Essilfie AT, Gellatly SL, Kim RY, Brown AC, Foster PS, Horvat JC, Hansbro PM. Murine models of infectious exacerbations of airway inflammation. Curr. Opin. Pharmacol. 2013; 13: 337–44.
127. Starkey MR, Essilfie AT, Horvat JC, Kim RY, Nguyen DH, Beagley KW, Mattes J, Foster PS, Hansbro PM. Constitutive production of IL-13 promotes early-life Chlamydia respiratory infection and allergic airway disease. Mucosal Immunol. 2013; 6: 569–79.
128. Starkey MR, Nguyen DH, Essilfie AT, Kim RY, Hatchwell LM, Collison AM, Yagita H, Foster PS, Horvat JC, Mattes J et al. Tumor necrosis factor-related apoptosis-inducing ligand translates neonatal respiratory infection into chronic lung disease. Mucosal Immunol. 2014; 7: 478–88.
129. King PT, Sharma R, O'Sullivan K, Selemidis S, Lim S, Radhakrishna N, Lo C, Prasad J, Callaghan J, McLaughlin P et al. Nontypeable Haemophilus influenzae induces sustained lung oxidative stress and protease expression. PLoS One 2015; 10: e0120371.
130. Hsu AC, Parsons K, Barr I, Lowther S, Middleton D, Hansbro PM, Wark PA. Critical role of constitutive type I interferon response in bronchial epithelial cell to influenza infection. PLoS One 2012; 7: e32947.
131. Tang FS, Hansbro PM, Burgess JK, Ammit AJ, Baines KJ, Oliver BG. A novel immunomodulatory function of neutrophils on rhinovirus-activated monocytes in vitro. Thorax 2016. doi: 10.1136/thoraxjnl-2015-207781.
132. Huang YJ, Sethi S, Murphy T, Nariya S, Boushey HA, Lynch SV. Airway microbiome dynamics in exacerbations of chronic obstructive pulmonary disease. J. Clin. Microbiol. 2014; 52: 2813–23.
133. Rogers GB, Wesselingh S. Precision respiratory medicine and the microbiome. Lancet Respir. Med. 2016; 4: 73–82.
134. van Nood E, Vrieze A, Nieuwdorp M, Fuentes S, Zoetendal EG, de Vos WM, Visser CE, Kuijper EJ, Bartelsman JF, Tijssen JG et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N. Engl. J. Med. 2013; 368: 407–15.
135. Mortaz E, Adcock IM, Folkerts G, Barnes PJ, Paul Vos A, Garssen J. Probiotics in the management of lung diseases. Mediators Inflamm. 2013; 2013: 751068.